Edgen AI operates independently of, and is not controlled by Aspen Digital Financial Limited.
AARD Dividend: Aardvark Therapeutics Inc Yield Insights
Back
Home
Stock
AARD
Aardvark Therapeutics Inc (AARD) Price
AARD Stock Price Chart
AARD Financial
Aardvark Therapeutics Inc
$6.4
20.3%
$1.08
At close: -- GMT-4
$6.4
0%
$0
Post-market: Jul 30, 19:15:19 GMT-4
Overview
Forecast
Earnings
Dividends
Financials
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Market Sentiment
Technical Analysis
Crypto Comparison
Home Page
Trading Strategies
Megabrain Investors Picks
Trading Mindshare
Technical Signals
Pivot Alert
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
Stocks Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2025 Edgen Powered by
Ask AI About AARD
Income
Balance sheet
Cash flow
Annual
Quarterly
AARD Income
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Revenue
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
Gross Profit
--
--
--
--
--
Selling, General & Admin
16
13
5
2
3
Research & Development
57
48
17
4
7
Operating Expenses
74
62
22
7
10
Other Non Operating Income (Expenses)
--
--
--
--
--
Pretax Income
-69
-57
-20
-7
-13
Income Tax Expense
--
0
--
0
0
Net Income
-69
-57
-20
-7
-13
Net Income Growth
138%
185%
186%
-46%
--
Shares Outstanding (Diluted)
21.81
19.62
21.38
21.38
21.38
Shares Change (YoY)
65%
-8%
0%
0%
--
EPS (Diluted)
-3.21
-2.93
-0.96
-0.33
-0.63
EPS Growth
42%
204.99%
186%
-47%
--
Free Cash Flow
-61
-54
-18
-5
-10
Free Cash Flow Per Share
-2.79
-2.75
-0.84
-0.23
-0.46
Gross Margin
--
--
--
--
--
Operating Margin
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
EBITDA
-74
-62
-22
-7
-10
EBITDA Margin
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
EBIT
-74
-62
-22
-7
-10
EBIT Margin
0%
0%
0%
0%
0%
Effective Tax Rate
--
0%
--
0%
0%
Follow-Up Questions
What are Aardvark Therapeutics Inc's key financial statements?
What are the key financial ratios for AARD?
How is Aardvark Therapeutics Inc's revenue broken down by segment or geography?
Is Aardvark Therapeutics Inc profitable?
Does Aardvark Therapeutics Inc have any liabilities?
How many outstanding shares for Aardvark Therapeutics Inc?